Trident Texofab Ltd Stock Falls to 52-Week Low of Rs.71.3

Stock Performance and Market Context

On 2 March 2026, Trident Texofab Ltd opened sharply lower by 5.00%, immediately hitting the intraday low of Rs.71.3, which it maintained throughout the trading session. This price represents a steep fall from its 52-week high of Rs.379, underscoring a substantial depreciation of 81.2% over the past year. The stock has been on a persistent downward trajectory, declining for 21 consecutive trading days and delivering a cumulative return of -65.8% during this period.

In comparison, the broader Sensex index has shown resilience, trading at 79,713.36 points despite a volatile session that saw an initial gap down of 2,743.46 points before recovering 1,169.63 points. The Sensex’s 1-year return stands at a positive 8.90%, highlighting the stark contrast with Trident Texofab’s performance.

Within the Garments & Apparels sector, the stock has underperformed as well, with sector trading down by 2.52% today, while Trident Texofab lagged further by underperforming the sector by 2.16%. The stock currently trades below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling sustained bearish momentum.

Financial Metrics and Fundamental Assessment

Trident Texofab’s financial profile reveals several areas of concern that have contributed to its subdued market valuation. The company’s long-term fundamental strength is considered weak, with an average Return on Capital Employed (ROCE) of 6.88%, which is below industry standards. This metric indicates limited efficiency in generating profits from its capital base.

Debt servicing capacity is another critical factor, with the company exhibiting a high Debt to EBITDA ratio of 6.83 times. Such leverage levels suggest elevated financial risk and potential strain on cash flows, which may have influenced investor sentiment negatively.

Quarterly results for December 2025 further reflect subdued performance, with net sales reported at Rs.25.74 crores, marking the lowest quarterly sales figure in recent periods. This flat sales performance adds to the challenges faced by the company in maintaining growth momentum.

Over the past year, the stock has generated a negative return of -59.23%, underperforming not only the Sensex but also the BSE500 index across multiple time frames including the last three years, one year, and three months. This consistent underperformance highlights structural issues affecting the company’s market standing.

Valuation and Relative Positioning

Despite the negative price action, certain valuation metrics suggest the stock is trading at a discount relative to its peers. The company’s ROCE of 7.4% combined with an Enterprise Value to Capital Employed ratio of 1.6 indicates an attractive valuation on a relative basis. Furthermore, the company’s profits have increased by 122.5% over the past year, a notable improvement amid the price decline, resulting in a PEG ratio of 0.7. This metric implies that the stock’s price decline has outpaced earnings growth.

Majority shareholding remains with non-institutional investors, which may influence liquidity and trading dynamics in the stock.

Market Grade and Analyst Scores

According to MarketsMOJO’s latest assessment dated 3 February 2026, Trident Texofab Ltd carries a Mojo Score of 23.0 and a Mojo Grade of Strong Sell, an upgrade in severity from the previous Sell rating. The Market Cap Grade stands at 4, reflecting the company’s relatively modest market capitalisation within its sector. These ratings underscore the cautious stance reflected in the stock’s recent price behaviour.

The downgrade in sentiment is consistent with the company’s financial and market performance metrics, reinforcing the challenges faced by the stock in regaining investor confidence.

Sector and Broader Market Dynamics

The Garments & Apparels sector has experienced a decline of 2.52% in trading today, indicating sector-wide pressures. Trident Texofab’s sharper fall relative to the sector suggests company-specific factors are amplifying the negative trend. Meanwhile, the Sensex’s recovery from a steep gap down opening to a less severe loss of 1.94% reflects broader market resilience that contrasts with the stock’s performance.

Technical indicators show the Sensex trading below its 50-day moving average, although the 50-day average remains above the 200-day average, signalling a mixed medium-term outlook for the broader market.

Summary of Key Price and Performance Data

To summarise, Trident Texofab Ltd’s stock has:

• Hit a new 52-week low of Rs.71.3 on 2 March 2026
• Declined by 5.00% on the day, opening at the low price
• Experienced 21 consecutive days of price decline, losing 65.8% in that period
• Underperformed the Garments & Apparels sector by 2.16% today
• Delivered a one-year return of -59.23%, compared to Sensex’s +8.90%
• Maintained trading below all major moving averages

These data points collectively illustrate the stock’s current position at a significant low point within its trading range.

Conclusion

Trident Texofab Ltd’s fall to its 52-week low of Rs.71.3 reflects a confluence of factors including weak long-term financial metrics, elevated leverage, subdued sales figures, and sustained negative price momentum. While valuation metrics indicate some relative attractiveness, the stock’s performance remains challenged within a sector and market environment that has shown greater resilience. The company’s recent downgrade to a Strong Sell rating by MarketsMOJO further emphasises the cautious outlook prevailing among market analysts.

Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →